Evaluation of Continuous Glucose Monitoring Systems in Pediatrics with Diabetes

Trial Design: Participants will wear up to 3 study CGM systems for up to 16 days
Inclusion Criteria:
Ages between 2-17
Clinical diagnosis of type 1 or type 2 diabetes
Principal Investigator: Kristin Castorino
Status: Recruiting

View Official Trial Listing